Skip to main content
. 2016 Nov 2;11(11):e0162752. doi: 10.1371/journal.pone.0162752

Fig 1. Inclusion flow chart.

Fig 1

Flow chart of patients by country for IFNβ (left side) and natalizumab (right side) treated patients.